Gamma interferon-induced nitric oxide production in mouse CD5+ B1-like cell line and its association with apoptotic cell death

Microbiology and Immunology

Volumn 47, Issue 9, 2003, Pages 669-679

  Koide, Naoki ^a   Sugiyama, Tsuyoshi ^a   Mu, Mya Mya ^a   Mori, Isamu ^a   Yoshida, Tomoaki ^a   Hamano, Teruaki ^b   Yokochi, Takashi ^a  

^a AICHI MEDICAL UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Apoptosis; IFN , B1 cell; Nitric oxide

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3; CELL MARKER; CYTOKINE; DNA FRAGMENT; GAMMA INTERFERON; INTERLEUKIN 4; JANUS KINASE; JANUS KINASE 2 INHIBITOR; LIPOCORTIN 5; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN TYROSINE KINASE INHIBITOR; STAT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; B1 LIKE CELL LINE; CELL DEATH; CONTROLLED STUDY; HYBRIDOMA CELL CULTURE; IMMUNOSTIMULATION; IN VITRO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; SPLEEN CELL; TH2 CELL;

ANIMALIA; JANUS;

EID: 0141480292     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2003.tb03430.x     Document Type: Article

References (43)

1. Beckman, J.S., and Koppenol, W.H. 1996. Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly, Am. J. Physiol. 271: 1424-1437.
2. Bogdan, C., Rollinghoff, M., and Diefenbach, A. 2000. The role of nitric oxide in innate immunity. Immunol. Rev. 173: 17-26.
3. Borrello, M.A., and Phipps, R.P. 1995. Fibroblasts support outgrowth of splenocytes simultaneously expressing B lymphocyte and macrophage characteristics. J. Immunol. 155: 4155-4161.
4. Borrello, M.A., and Phipps, R.P. 1999. Fibroblast-secreted macrophage colony-stimulating factor is responsible for generation of biphenotypic B/macrophage cells from a subset of mouse B lymphocytes. J. Immunol. 163: 3605-3611.
5. Bredt, D.S. 1999. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic. Res. 31: 577-596.
6. Brune, B., von Knethen, A., and Sandau, K.B. 1998. Nitric oxide and its role in apoptosis. Eur. J. Pharmacol. 351: 261-272.
7. Brune, B., von Knethen, A., and Sandau, K.B. 1999. Nitric oxide (NO): an effector of apoptosis. Cell Death Differ. 6: 969-975.
8. Buschle, M., Campana, D., Carding, S.R., Richard, C., Hoffbrand, A.V., and Brenner, M.K. 1993. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J. Exp. Med. 177: 213-218.
9. 2-terminal kinase/stress-activated protein kinase in RAW 264.7 murine macrophage cells. Infect. Immun. 69: 1315-1321.
10. Cohen, G.M. 1997. Caspases: the executioners of apoptosis. Biochem. J. 326: 1-16.
11. Darnell, J.E., Jr., Kerr, I.M., and Stark, G.R. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421.
12. Dickensheets, H.L., Venkataraman, C., Schindler, U., and Donnelly, R.P. 1999. Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proc. Natl. Acad. Sci. U.S.A. 96: 10800-10805.
13. Dimmeler, S., and Zeiher, A.M. 1997. Nitric oxide and apoptosis: another paradigm for the double-edge role of nitric oxide. Nitric Oxide Biol. Chem. 1: 275-281.
14. + B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur. J. Immunol. 17: 521-528.
15. 15N nitrate in biological fluids. Anal. Biochem. 1236: 131-138.
16. Hamano, T., Kim, K.J., Leiserson, W.M., and Asofsky, R. 1982. Establishment of B cell hybridomas with B cell surface antigens. J. Immunol. 129: 1403-1406.
17. Ihle, J.N. 1995. The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv. Immunol. 60: 1-35.
18. Kasaian, M.T., and Casali, P. 1993, Autoimmunity-prone B-1 (CD5 B) cells, natural antibodies and self recognition. Autoimmunity 15: 315-329.
19. Kasaian, M.T., and Casali, P. 1995. B-1 cellular origin and VH segment structure of IgG, IgA, and IgM anti-DNA autoantibodies in patients with systemic lupus erythematosus. Ann. N.Y. Acad. Sci. 764: 410-423.
20. Kearney, J.F., McCarthy, M.T., Stohrer, R., Benjamin, W.H., Jr., and Briles, D.E. 1985. Induction of germ-line anti-alpha 1-3 dextran antibody responses in mice by members of the Enterobacteriaceae family. J. Immunol. 135: 3468-3472.
21. Kelly, C.J., and Gold, D.P. 1999. Nitric oxide in interstitial nephritis and other autoimmune diseases. Semin. Nephrol. 19:288-295.
22. Koide, N., Sugiyama, T., Kato, Y., Chakravortty, D., Mu, M.M., Yoshida, T., Hamano, T., and Yokochi, T. 2001. Mouse B1 cell line responds to lipopolysaccharide via membrane-bound CD14. J. Endotoxin Res. 7: 39-43.
23. + B1 cells to a macrophage-like morphology by gamma interferon and its inhibition by interleukin-4. Clin. Diagn. Lab. Immunol. 9: 1169-1174.
24. Kroncke, K.D., Fehsel, K., and Kolb-Bachofen, V. 1997. Nitric oxide: cytotoxicity versus cytoprotection how, why and where? Nitric Oxide Biol. Chem. 1: 107-120.
25. Little, J., Alling, D.W., and Asofsky, R. 1993. Induction of differentiation in a B lymphoma×B lymphocyte hybrid line. II. Intraclonal heterogeneity in growth, secretion of IgM, and cytokine production in response to lipopolysaccharide. J. Immunol. 150: 2129-2138.
26. Liu, S.F., Ye, X., and Malik, A.B. 1997. In vivo inhibition of NF-κB activation prevents iNOS synthase expression and systemic hypotension in a rat model of septic shock. J. Immunol. 159: 3976-3983.
27. MacMicking, J., Xie, Q.W., and Nathan, C. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15: 323-350.
28. Magazine, H.I. 1995. Detection of endothelial cell derived nitric oxide: current trends and future directions. Adv. Neuroimmunol. 5: 479-490.
29. + (CD5) B cells that recognize phosphatidyl cholin. Relationship to cells that secrete hemolytic antibody specific for autologous erythrocytes. J. Exp. Med. 168: 687-698.
30. Morikawa, A., Kato, Y., Sugiyama, T., Koide, N., Chakravortty, D., Yoshida, T., and Yokochi, T. 1999. Role of nitric oxide in lipopolysaccharide- induced hepatic injury in D-galactosamine-sensitized mice as an experimental endotoxic shock model. Infect. Immun. 67: 1018-1024.
31. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6: 3051-3064.
32. Nguyen, V.T., and Benveniste, E.N. 2000. IL-4-activated STAT-6 inhibits IFN-gamma-induced CD40 gene expression in macrophages/microglia. J. Immunol. 165: 6235-6243.
33. Ohmori, Y., and Hamilton, T.A. 1997. IL-4-induced STAT6 suppresses IFN-γ-stimulated STAT1-dependent transcription in mouse macrophages. J. Immunol. 159: 5474-5482.
34. Porter, A.G., and Janicke, R.U. 1999. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6: 99-104.
35. + B lymphocytes in the peripheral blood of patients with myasthenia gravis. Neurology 40: 1120-1124.
36. Rao, K.M. 2000. Molecular mechanisms regulating iNOS expression in various cell types. J. Toxicol. Environ. Health B Crit. Rev. 3: 27-58.
37. Raupach, B., and Kaufmann, S.H. 2001. Immune responses to intracellular bacteria. Curr. Opin. Immunol. 13: 417-428.
38. Rojas, R., Roman, J., Torres, A., Ramirez, R., Carracedo, J., Lopez, R., and Garcia, J.M. 1996. Inhibition of apoptotic cell death in B-CLL by interferon gamma correlates with clinical stage. Leukemia 10: 1782-1788.
39. Santiago, E.L., Perez-Mediavilla, A., and Lopez-Moratalla, N. 1998. The role of nitric oxide in the pathogenesis of multiple sclerosis. J. Physiol. Biochem. 54: 229-237.
40. + T cells. Annu. Rev. Immunol. 12: 635-673.
41. Su, S.D., Ward, M.M., Apicella, M.A., and Ward, R.E. 1991. The primary B cell response to the O/core region of bacterial lipopolysaccharide is restricted to the Ly-1 lineage. J. Immunol. 146: 327-331.
42. Titheradge, M.A. 1999. Nitric oxide in septic shock. Biochim. Biophys. Acta 1411: 437-455.
43. Willenborg, D.O., Staykova, M.A., and Cowden, W.B. 1999. Our shifting understanding of the role of nitric oxide in autoimmune encephalomyelitis. J. Neuroimmunol. 100: 21-35.